🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 11 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/11/2017 16,17 17,50 16,17 17,40 +6,95% 8,23% 97.800
16/11/2017 16,56 16,74 16,15 16,27 -0,37% 3,56% 170.700
15/11/2017 16,47 16,95 16,12 16,33 -1,45% 5,04% 126.900
14/11/2017 16,92 16,92 16,21 16,57 -2,30% 4,20% 108.200
13/11/2017 17,00 17,38 16,52 16,96 -0,53% 5,06% 152.100
10/11/2017 17,05 17,44 16,55 17,05 +0,12% 5,19% 236.200
09/11/2017 16,99 17,39 16,27 17,03 +0,12% 6,56% 171.800
08/11/2017 16,06 17,28 15,74 17,01 +6,51% 9,59% 314.200
07/11/2017 14,85 16,31 14,85 15,97 +8,57% 9,83% 349.300
06/11/2017 14,79 15,11 14,43 14,71 +0,27% 4,60% 45.500
03/11/2017 14,39 14,79 14,36 14,67 +1,38% 2,99% 94.200
02/11/2017 14,44 14,88 14,10 14,47 -0,41% 5,37% 70.100
01/11/2017 15,17 15,17 14,31 14,53 -2,94% 5,67% 73.300
31/10/2017 15,36 15,36 14,95 14,97 -1,71% 2,67% 37.100
30/10/2017 15,42 15,70 14,90 15,23 -0,91% 5,19% 63.700
27/10/2017 15,33 15,62 14,93 15,37 +2,81% 4,53% 123.800
26/10/2017 15,57 15,98 14,75 14,95 -3,98% 7,90% 172.100
25/10/2017 15,63 15,74 15,45 15,57 -0,13% 1,86% 51.600
24/10/2017 15,76 16,03 15,35 15,59 -0,89% 4,30% 78.400
23/10/2017 15,93 16,19 15,55 15,73 -1,26% 4,02% 52.800
20/10/2017 16,52 16,70 15,89 15,93 -1,97% 4,90% 203.700
19/10/2017 16,49 16,62 16,08 16,25 -1,63% 3,27% 73.300
18/10/2017 16,23 16,98 16,23 16,52 +1,98% 4,62% 85.800
17/10/2017 15,82 16,46 15,60 16,20 +1,63% 5,44% 111.800
16/10/2017 15,73 16,48 15,68 15,94 -2,57% 5,12% 167.400
13/10/2017 17,01 17,21 15,79 16,36 -2,33% 8,37% 322.600
12/10/2017 17,89 17,89 16,26 16,75 -15,45% 9,11% 1.436.400
11/10/2017 19,88 19,95 19,15 19,81 +0,71% 4,02% 40.500
10/10/2017 19,20 19,69 18,33 19,67 +3,20% 7,08% 34.300
09/10/2017 18,60 19,94 18,56 19,06 +1,60% 7,42% 37.500